Cresset, innovative provider of computational software and services for small molecule drug discovery and design is joining the 3D-NEONET consortium of academics and SMEs. The consortium, which is funded through the EU’s Horizon 2020 program, was created to enhance the sharing of technologies and the...
Medilink UK, the largest representative body for the Health Technology sector in the UK, has appointed Mr Kevin Kiely as its CEO. Kevin was co-founder of the Medilink model over twenty five years ago, which for the first time brought together in a formal regional association,...
Pictured L-R: Dr Sharon Cheetham, Director and Dr Wioletta Pijacka, Study Director Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the appointment of Dr Wioletta Pijacka. Wioletta is an in vivo...
Today Charnwood Molecular announce that Synova Capital has completed a significant investment. The deal will provide Charnwood with additional investment to support its continued development and growth. Synova will support Charnwood to deliver an ambitious growth plan, built upon increasing investment in the Business’s core capabilities...
Scottish Business Insider’s tech columnist Michael Feeley picks a diverse crop of firms with serious growth potential Novosound Established in 2018 by Dave Hughes, CTO, and Richard Cooper, CEO, as a spin-out from the University of the West of Scotland, Novosound’s patented technology eliminates limitations associated with...
Working in collaboration with teams at the German Cancer Research Center and the Pivot Park Screening Centre, BioAscent scientists have helped to discover potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. The findings have been published in ChemMedChem...
BioAscent has appointed former PhD placement student, George Pandarakalam, as a Senior Scientist in its Biology team. George came to the UK from India in 2008 to complete an MSc in Biotechnology with Bio-Business at the University of Aberdeen, before completing his PhD in 2016. Throughout 2015...
BioCity, the pioneering life science incubator and business collective this week received a festive makeover thanks to a nationwide Christmas competition to deck the halls. Now a much-loved Christmas tradition, each year, BioCity holds a creative competition and invites all those within their collective of more...
Cambridge, UK – 4th December 2019 – Cresset Discovery Services, provider of contract research services for early phase discovery, is pleased to announce it has been contracted by PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, to work on a novel...
10th December 2019 Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) are launching a platform which aims to support companies with the rapid development of both standard and complex drug products. The new enabling technology screening platform, integrates the company’s existing formulation capabilities...